Biomaterial Database

Potential long term vaccine benefits poorly translate in cost effectiveness modelling. 2014

Steven Black

Center for Global Health, Cincinnati Children's Hospital, Cincinnati, OH, USA stevblack@gmail.com.

UI	MeSH Term	Description	Entries
D008585	Meningitis, Meningococcal	A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8)	Meningitis, Neisseria,Neisseria Meningitis,Meningitis, Meningococcal, Serogroup A,Meningitis, Meningococcal, Serogroup B,Meningitis, Meningococcal, Serogroup C,Meningitis, Meningococcal, Serogroup W-135,Meningitis, Meningococcal, Serogroup W135,Meningitis, Meningococcal, Serogroup Y,Meningitis, Meningococcic,Meningococcal Meningitis, Serogroup A,Meningococcal Meningitis, Serogroup B,Meningococcal Meningitis, Serogroup C,Meningococcal Meningitis, Serogroup W-135,Meningococcal Meningitis, Serogroup W135,Meningococcal Meningitis, Serogroup Y,Serogroup A Meningococcal Meningitis,Serogroup B Meningococcal Meningitis,Serogroup C Meningococcal Meningitis,Serogroup W-135, Meningococcal Meningitis,Serogroup W135, Meningococcal Meningitis,Serogroup Y, Meningococcal Meningitis,Meningococcal Meningitis,Meningococcal Meningitis, Serogroup W 135,Neisseria Meningitides,Serogroup W 135, Meningococcal Meningitis
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018803	Models, Economic	Statistical models of the production, distribution, and consumption of goods and services, as well as of financial considerations. For the application of statistics to the testing and quantifying of economic theories MODELS, ECONOMETRIC is available.	Economic Models,Economic Model,Model, Economic
D022401	Meningococcal Vaccines	Vaccines or candidate vaccines used to prevent infection with NEISSERIA MENINGITIDIS.	Bivalent Meningococcal Vaccine,Menactra,Meningococcal Polysaccharide Vaccine,Meningococcal Vaccine,Menomune,Menveo,Tetravalent Meningococcal Vaccine,Meningococcal Vaccine, Bivalent,Meningococcal Vaccine, Tetravalent,Polysaccharide Vaccine, Meningococcal,Vaccine, Meningococcal,Vaccine, Meningococcal Polysaccharide,Vaccines, Meningococcal
D032541	Mass Vaccination	Administration of a vaccine to large populations in order to elicit IMMUNITY.	Mass Immunization,Immunization, Mass,Mass Immunizations,Mass Vaccinations,Vaccination, Mass